Business Context and Reporting Period
Company: Moderna, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 11, 2020
Event: Entry into a Material Definitive Agreement for a public offering of common stock.
Key Financial Metrics
This filing details a capital raise rather than operational financial performance. Key metrics related to the offering include:
- Shares Issued: 26,315,790 shares of common stock.
- Offering Price: $19.00 per share.
- Estimated Net Proceeds (Base): Approximately $478.1 million.
- Over-Allotment Option: Underwriters granted an option to purchase up to 3,947,368 additional shares.
- Estimated Net Proceeds (With Full Option): Approximately $549.9 million.
- Underwriters: Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC.
Note: The filing text does not provide values for revenue, profit, cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the execution of an underwriting agreement to raise significant capital. The company expects the offering to close on or about February 14, 2020, subject to customary closing conditions. This represents a substantial increase in the company's cash liquidity upon closing.
Guidance, Outlook, and Risks
Management Commentary: The company issued a press release on February 11, 2020, announcing the pricing of the offering (incorporated by reference as Exhibit 99.1). The filing does not contain specific forward-looking guidance regarding product development timelines or future revenue projections beyond the capital raise.
Risks and Contingencies: The closing of the offering is subject to customary closing conditions. The description of the Underwriting Agreement is qualified by reference to the complete text filed as Exhibit 1.1.
Investor Verification Checklist
- Verify the final closing date of the offering (expected February 14, 2020).
- Confirm whether the underwriters exercised the option to purchase the additional 3,947,368 shares.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific terms, covenants, and use of proceeds.
- Check the press release (Exhibit 99.1) for management's stated intent for the raised capital.
